Home › Funds › HSG Holding Ltd › GYRE

HSG Holding Ltd position in GYRE

GYRE THERAPEUTICS INC · Health Care

HSG Holding Ltd reported holding 3,750,299 shares of GYRE (GYRE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$27.5M, representing 2.17% of its reported portfolio and ranking #8 among its reported holdings. HSG Holding Ltd has disclosed GYRE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)3.75M sh
Reported value held$27.49M
Portfolio Weight2.17%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HSG Holding Ltd's GYRE position evolved

HSG Holding Ltd first disclosed a stake in GYRE in Q2 2026 at 3,750,299 shares (US$24.7M). The position peaked in Q3 2026 at 3,750,299 shares, worth US$27.5M. Across 2 filings, HSG Holding Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,750,299 shares valued at US$27.5M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 3.75M $24.71M New
Q3 2026 3.75M $27.49M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GYRE and 13F data

GYRE (GYRE THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in GYRE — the largest reported positions include Octagon Capital Advisors LP (US$6.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GYRE

All GYRE fund holders →

FAQ

How long has HSG Holding Ltd held GYRE?

HSG Holding Ltd has disclosed GYRE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is HSG Holding Ltd's current position in GYRE?

As of Q3 2026, HSG Holding Ltd holds 3.75M shares of GYRE (GYRE THERAPEUTICS INC), valued at $27.49M, representing 2.17% of its reported portfolio and ranking #8.

Has HSG Holding Ltd been buying or selling GYRE?

In the latest 13F filing (Q3 2026), HSG Holding Ltd held unchanged its position in GYRE. The position peaked in Q3 2026 at 3.75M shares.

Which other funds hold GYRE?

Other major institutional holders of GYRE include Octagon Capital Advisors LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.